Cargando…

Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image

BACKGROUND: The detection of phosphatidylinositol-3 kinase catalytic alpha (PIK3CA) gene mutations in breast cancer is a key step to design personalizing an optimal treatment strategy. Traditional genetic testing methods are invasive and time-consuming. It is urgent to find a non-invasive method to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Wen-Qian, Guo, Yanhui, Ru, Wan-Er, Li, Cheukfai, Zhang, Guo-Chun, Liao, Ning, Du, Guo-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204315/ https://www.ncbi.nlm.nih.gov/pubmed/35719907 http://dx.doi.org/10.3389/fonc.2022.850515

Ejemplares similares

PIK3CA in Colorectal Cancer
por: Cathomas, Gieri
Publicado: (2014)

Case Report: Kaposiform hemangioendothelioma with PIK3CA mutation successfully treated with sirolimus
por: Wang, Zuopeng, et al.
Publicado: (2023)

The Spectrum, Tendency and Predictive Value of PIK3CA Mutation in Chinese Colorectal Cancer Patients
por: Fu, Xinhui, et al.
Publicado: (2021)

Association of Body Mass Index With Somatic Mutations in Breast Cancer
por: Chen, Bo, et al.
Publicado: (2021)

Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma
por: Rieke, Damian T., et al.
Publicado: (2023)

PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
por: Fusco, Nicola, et al.
Publicado: (2021)

Prevalence of PIK3CA mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysis
por: Chao, Ta-Chung, et al.
Publicado: (2023)

FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration
por: Li, Sisi, et al.
Publicado: (2021)

Longitudinal Monitoring of EGFR and PIK3CA Mutations by Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports
por: Li, Ning, et al.
Publicado: (2020)

Mutations of PIK3CA in gastric adenocarcinoma
por: Li, Vivian Sze Wing, et al.
Publicado: (2005)

Mutations in PIK3CA are infrequent in neuroblastoma
por: Dam, Vincent, et al.
Publicado: (2006)

PIK3CA-mutations in breast cancer
por: Reinhardt, Kristin, et al.
Publicado: (2022)

The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a PIK3CA-mutated endometrial cancer
por: Passarelli, Anna, et al.
Publicado: (2023)

Oncogenic PIK3CA Mutation and Dysregulation in Human Salivary Duct Carcinoma
por: Qiu, Wanglong, et al.
Publicado: (2014)

Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer
por: Li, Weihua, et al.
Publicado: (2020)

Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
por: Guo, Fang, et al.
Publicado: (2018)

Mutation of the PIK3CA oncogene in human cancers
por: Karakas, B, et al.
Publicado: (2006)

Initiating breast cancer by PIK3CA mutation
por: Miller, Todd W
Publicado: (2012)

PIK3CA Mutations in Hepatocellular Carcinoma in Korea
por: Kim, Heesue, et al.
Publicado: (2013)

PIK3CA Mutational Analysis of Parathyroid Adenomas
por: Riccardi, Aaliyah, et al.
Publicado: (2020)

PIK3CA somatic alterations in invasive breast cancers: different spectrum from Caucasians to Chinese detected by next generation sequencing
por: Jia, Minghan, et al.
Publicado: (2021)

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
por: Deshpande, Vikram, et al.
Publicado: (2011)

Somatic mutation and gain of copy number of PIK3CA in human breast cancer
por: Wu, Guojun, et al.
Publicado: (2005)

Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models
por: Davis, S. Lindsey, et al.
Publicado: (2015)

EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
por: BUJKO, MATEUSZ, et al.
Publicado: (2014)

PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes
por: Janku, Filip, et al.
Publicado: (2012)

Cancer-Associated PIK3CA Mutations in Overgrowth Disorders
por: Madsen, Ralitsa R., et al.
Publicado: (2018)

PIK3CA mutation and colorectal cancer precision medicine
por: Hamada, Tsuyoshi, et al.
Publicado: (2017)

Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
por: Hao, Yujun, et al.
Publicado: (2016)

Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
por: Hutchinson, Katherine E., et al.
Publicado: (2023)

PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival
por: Cochicho, Daniela, et al.
Publicado: (2022)

Characterization of Driver Mutations in Anaplastic Thyroid Carcinoma Identifies RAS and PIK3CA Mutations as Negative Survival Predictors
por: Lai, Wei-An, et al.
Publicado: (2020)

Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
por: Chen, Li, et al.
Publicado: (2018)

Carcinogenesis of PIK3CA
por: German, Sidra, et al.
Publicado: (2013)

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases
por: Palimaru, Irina, et al.
Publicado: (2013)

A Mosaic PIK3CA Mutation in a Moroccan Female: Exploring the Diagnostic Challenges of PIK3CA-Related Overgrowth Spectrum
por: Ahakoud, Mohamed, et al.
Publicado: (2023)

PIK3CA Is Regulated by CUX1, Promotes Cell Growth and Metastasis in Bladder Cancer via Activating Epithelial-Mesenchymal Transition
por: Wang, Zhongyu, et al.
Publicado: (2020)

The role of the PIK3CA gene in the development and aging of the brain
por: Xie, Shaozhen, et al.
Publicado: (2021)

Concomitant PIK3CA and TP53 Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis
por: Lin, Xiao-Yi, et al.
Publicado: (2023)

Detection of PIK3CA Mutations in Breast Cancer Bone Metastases
por: Daneshmand, Manijeh, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dt88lrr716tsd1udbn9meojhun